Total Payments
$70,113
2021 Payments
$4,315
Companies
9
Transactions
45
Medicare Patients
199
Medicare Billing
$47,423
Payment Breakdown by Category
Consulting$46,843 (66.8%)
Travel$17,603 (25.1%)
Other$4,620 (6.6%)
Food & Beverage$1,048 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $46,843 | 16 | 66.8% |
| Travel and Lodging | $17,603 | 16 | 25.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,620 | 1 | 6.6% |
| Food and Beverage | $1,048 | 12 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $57,779 | 32 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $3,263 | 3 | $0 (2018) |
| Celgene Corporation | $3,000 | 1 | $0 (2020) |
| Global Blood Therapeutics, Inc. | $2,350 | 1 | $0 (2021) |
| CHIESI USA, INC. | $2,100 | 1 | $0 (2020) |
| PFIZER INC. | $1,387 | 4 | $0 (2018) |
| CSL Behring | $124.57 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $75.45 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $34.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $4,315 | 2 | Global Blood Therapeutics, Inc. ($2,350) |
| 2020 | $16,890 | 7 | Novartis Pharmaceuticals Corporation ($11,790) |
| 2019 | $33,271 | 18 | Novartis Pharmaceuticals Corporation ($33,271) |
| 2018 | $2,462 | 7 | PFIZER INC. ($1,387) |
| 2017 | $13,175 | 11 | Novartis Pharmaceuticals Corporation ($10,653) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,965.00 | General |
| Category: HEMATOLOGY | ||||||
| 03/17/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | In-kind items and services | $2,350.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 12/10/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $2,620.00 | General |
| Category: HEMATOLOGY | ||||||
| 12/08/2020 | CHIESI USA, INC. | FERRIPROX (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: TRANSFUSIONAL IRON OVERLOAD DUE TO THALASSEMIA SYNDROMES | ||||||
| 11/10/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $2,620.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/08/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,965.00 | General |
| Category: HEMATOLOGY | ||||||
| 08/26/2020 | Celgene Corporation | REBLOZYL (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Hematology | ||||||
| 06/25/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $3,275.00 | General |
| Category: HEMATOLOGY | ||||||
| 06/02/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,310.00 | General |
| Category: HEMATOLOGY | ||||||
| 12/19/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | ADAKVEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,620.00 | General |
| Category: HEMATOLOGY | ||||||
| 12/19/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $476.00 | General |
| 12/19/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $262.74 | General |
| Category: HEMATOLOGY | ||||||
| 12/19/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $157.60 | General |
| Category: HEMATOLOGY | ||||||
| 12/19/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| Category: HEMATOLOGY | ||||||
| 12/19/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: HEMATOLOGY | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $3,930.00 | General |
| Category: HEMATOLOGY | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $190.13 | General |
| Category: HEMATOLOGY | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $70.74 | General |
| Category: HEMATOLOGY | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $22.18 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Consulting Fee | Cash or cash equivalent | $8,585.00 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $626.63 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $66.27 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $63.30 | General |
| Category: HEMATOLOGY | ||||||
| 06/11/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $50.15 | General |
| Category: HEMATOLOGY | ||||||
| 06/10/2019 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $12,648.00 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 151 | $90,655 | $12,777 |
| 2022 | 2 | 51 | 157 | $95,881 | $14,100 |
| 2021 | 2 | 46 | 112 | $68,348 | $10,223 |
| 2020 | 2 | 59 | 138 | $90,602 | $10,323 |
Total Patients
199
Total Services
558
Medicare Billing
$47,423
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 133 | $76,741 | $10,578 | 13.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 18 | $13,914 | $2,199 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 36 | 130 | $75,010 | $10,817 | 14.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 27 | $20,871 | $3,283 | 15.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 93 | $53,661 | $7,705 | 14.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 13 | 19 | $14,687 | $2,518 | 17.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 31 | 82 | $47,314 | $5,408 | 11.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 28 | 56 | $43,288 | $4,915 | 11.4% |
About Dr. Robert Hagar, M.D
Dr. Robert Hagar, M.D is a Internal Medicine healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760549182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hagar, M.D has received a total of $70,113 in payments from pharmaceutical and medical device companies, with $4,315 received in 2021. These payments were reported across 45 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($46,843).
As a Medicare-enrolled provider, Hagar has provided services to 199 Medicare beneficiaries, totaling 558 services with total Medicare billing of $47,423. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oakland, CA
- Active Since 01/03/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760549182
Products in Payments
- ADAKVEO (Biological) $46,426
- REBLOZYL (Biological) $3,000
- IW-1701 $2,363
- OXBRYTA (Drug) $2,350
- FERRIPROX (Drug) $2,100
- CRIZANLIZUMAB (Biological) $1,055
- Multiple Products (Biological) $124.57
- SOLIRIS (Drug) $34.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oakland
Jeffrey Burack, M.d, M.D
Internal Medicine — Payments: $592,777
Internal Medicine $592,777
Stephanie Christenson, Md, MD
Internal Medicine — Payments: $424,755
Internal Medicine $424,755
Min Yan, M.d, M.D
Internal Medicine — Payments: $45,508
Internal Medicine $45,508
Anita Chang, Md, MD
Internal Medicine — Payments: $27,813
Internal Medicine $27,813
Dr. Robert Bober, Md, MD
Internal Medicine — Payments: $26,112
Internal Medicine $26,112
Oluwayemisi Adejumo, M.d, M.D
Internal Medicine — Payments: $23,341
Internal Medicine $23,341